LATE STAGE DEVELOPMENT OF AN AUTOLOGOUS TUMOUR VACCINE FOR RENAL CELL CARCINOMA VCC MEDICAL DIVISION IS DEVELOPING CLINICALLY PROVEN PRODUCTS, SHOWN TO MAINTAIN REMISSION AND ALLEVIATE DISEASE VCC-001 cancer vaccine Phase III data in Renal Cell Cancer has demonstrated clinical effect and was well tolerated, a disease with few current treatment options VCC-001 cancer vaccine platform has significant potential in metastatic renal cell, colon and pancreatic cancers
View Top Employees from Vaccentis AG| Website | https://www.vaccentis.com |
| Employees | 5 (3 on RocketReach) |
| Founded | 2006 |
| Industry | Biotechnology Research, Medical Devices & Equipment, Manufacturing |
| SIC | SIC Code 384 Companies, SIC Code 38 Companies |
| NAICS | NAICS Code 339 Companies, NAICS Code 33 Companies |
Looking for a particular Vaccentis AG employee's phone or email?
Vaccentis AG Questions
Subhasis Roy is the Board Member of Vaccentis AG.
3 people are employed at Vaccentis AG.
Vaccentis AG is based in Zurich, Zurich.
The NAICS codes for Vaccentis AG are [339, 33].
The SIC codes for Vaccentis AG are [384, 38].
Top Vaccentis AG Employees
